• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构象在激活的β-2 肾上腺素能 G 蛋白偶联受体的对接筛选中指导分子效力。

Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.

机构信息

Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA 94158-2550, USA.

出版信息

ACS Chem Biol. 2013 May 17;8(5):1018-26. doi: 10.1021/cb400103f. Epub 2013 Mar 21.

DOI:10.1021/cb400103f
PMID:23485065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3658555/
Abstract

A prospective, large library virtual screen against an activated β2-adrenergic receptor (β2AR) structure returned potent agonists to the exclusion of inverse-agonists, providing the first complement to the previous virtual screening campaigns against inverse-agonist-bound G protein coupled receptor (GPCR) structures, which predicted only inverse-agonists. In addition, two hits recapitulated the signaling profile of the co-crystal ligand with respect to the G protein and arrestin mediated signaling. This functional fidelity has important implications in drug design, as the ability to predict ligands with predefined signaling properties is highly desirable. However, the agonist-bound state provides an uncertain template for modeling the activated conformation of other GPCRs, as a dopamine D2 receptor (DRD2) activated model templated on the activated β2AR structure returned few hits of only marginal potency.

摘要

一项针对激活的β2-肾上腺素能受体(β2AR)结构的前瞻性大型文库虚拟筛选,排除了反向激动剂,仅返回了强效激动剂,为之前针对与反向激动剂结合的 G 蛋白偶联受体(GPCR)结构的虚拟筛选提供了第一个补充,这些筛选仅预测了反向激动剂。此外,有两个命中物再现了与 G 蛋白和阻滞蛋白介导的信号转导相关的共结晶配体的信号转导特征。这种功能保真度在药物设计中具有重要意义,因为能够预测具有预定义信号特性的配体是非常理想的。然而,激动剂结合状态为建模其他 GPCR 的激活构象提供了一个不确定的模板,因为基于激活的β2AR 结构模板化的多巴胺 D2 受体(DRD2)激活模型返回的命中物数量很少,且效力也很有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee22/3658555/051a75a9a105/cb-2013-00103f_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee22/3658555/b938f0a35b05/cb-2013-00103f_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee22/3658555/9e03265f28f8/cb-2013-00103f_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee22/3658555/033ad697f203/cb-2013-00103f_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee22/3658555/051a75a9a105/cb-2013-00103f_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee22/3658555/b938f0a35b05/cb-2013-00103f_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee22/3658555/9e03265f28f8/cb-2013-00103f_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee22/3658555/033ad697f203/cb-2013-00103f_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee22/3658555/051a75a9a105/cb-2013-00103f_0005.jpg

相似文献

1
Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.构象在激活的β-2 肾上腺素能 G 蛋白偶联受体的对接筛选中指导分子效力。
ACS Chem Biol. 2013 May 17;8(5):1018-26. doi: 10.1021/cb400103f. Epub 2013 Mar 21.
2
Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.基于结构的 G 蛋白偶联受体配体功能预测:β-肾上腺素能受体案例研究。
J Chem Inf Model. 2015 May 26;55(5):1045-61. doi: 10.1021/acs.jcim.5b00066. Epub 2015 May 1.
3
Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?晶体结构是否排除了基于结构的虚拟筛选中 G 蛋白偶联受体理论模型的需要?
Proteins. 2012 Jun;80(6):1503-21. doi: 10.1002/prot.24035. Epub 2012 Mar 13.
4
Structural features of β2 adrenergic receptor: crystal structures and beyond.β2肾上腺素能受体的结构特征:晶体结构及其他
Mol Cells. 2015;38(2):105-11. doi: 10.14348/molcells.2015.2301. Epub 2014 Dec 24.
5
Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy.比较对接独特的 G 蛋白偶联受体构象只能产生具有激动剂效能的配体。
Mol Pharmacol. 2019 Dec;96(6):851-861. doi: 10.1124/mol.119.117515. Epub 2019 Oct 17.
6
Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.β2-肾上腺素能受体中 G 蛋白和可扩散配体作用的分子动力学模拟
J Mol Biol. 2011 Dec 9;414(4):611-23. doi: 10.1016/j.jmb.2011.10.015. Epub 2011 Oct 20.
7
Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody.β2-肾上腺素受体的肾上腺素激活结构由工程纳米抗体稳定。
Nature. 2013 Oct 24;502(7472):575-579. doi: 10.1038/nature12572. Epub 2013 Sep 22.
8
Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.基于对接的 G 蛋白偶联受体配体虚拟筛选:不仅是晶体结构,还有计算模型。
J Mol Graph Model. 2011 Feb;29(5):614-23. doi: 10.1016/j.jmgm.2010.11.005. Epub 2010 Nov 19.
9
Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists.基于结构导向的双重β2肾上腺素能/多巴胺D2受体激动剂的研发。
Bioorg Med Chem. 2016 Jun 15;24(12):2641-53. doi: 10.1016/j.bmc.2016.04.028. Epub 2016 Apr 19.
10
Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.鉴定 G 蛋白偶联受体中偏向配体设计的功能热点残基。
Mol Pharmacol. 2018 Apr;93(4):288-296. doi: 10.1124/mol.117.110395. Epub 2018 Jan 24.

引用本文的文献

1
Orphan G protein-coupled receptors: the ongoing search for a home.孤儿G蛋白偶联受体:仍在寻找归属
Front Pharmacol. 2024 Feb 29;15:1349097. doi: 10.3389/fphar.2024.1349097. eCollection 2024.
2
Identification of a β-arrestin-biased negative allosteric modulator for the β-adrenergic receptor.β-肾上腺素能受体的β-arrestin 偏向性负变构调节剂的鉴定。
Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2302668120. doi: 10.1073/pnas.2302668120. Epub 2023 Jul 25.
3
Structure-based discovery of conformationally selective inhibitors of the serotonin transporter.

本文引用的文献

1
A simple method for quantifying functional selectivity and agonist bias.一种量化功能选择性和激动剂偏向性的简单方法。
ACS Chem Neurosci. 2012 Mar 21;3(3):193-203. doi: 10.1021/cn200111m. Epub 2011 Dec 20.
2
Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists.β-arrestin 偏向性多巴胺 D₂ 受体激动剂的结构-功能选择性关系研究。
J Med Chem. 2012 Aug 23;55(16):7141-53. doi: 10.1021/jm300603y. Epub 2012 Aug 13.
3
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.
基于结构的 5-羟色胺转运体构象选择性抑制剂的发现。
Cell. 2023 May 11;186(10):2160-2175.e17. doi: 10.1016/j.cell.2023.04.010. Epub 2023 May 2.
4
Structure-based discovery of nonopioid analgesics acting through the α-adrenergic receptor.基于结构的非阿片类镇痛药通过 α-肾上腺素能受体作用的发现。
Science. 2022 Sep 30;377(6614):eabn7065. doi: 10.1126/science.abn7065.
5
Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs.利用构象稳定的单域抗体加速G蛋白偶联受体药物研发
Front Mol Biosci. 2022 May 23;9:863099. doi: 10.3389/fmolb.2022.863099. eCollection 2022.
6
BiasNet: A Model to Predict Ligand Bias Toward GPCR Signaling.BiasNet:一种预测配体对 GPCR 信号转导偏向性的模型。
J Chem Inf Model. 2021 Sep 27;61(9):4190-4199. doi: 10.1021/acs.jcim.1c00317. Epub 2021 Aug 16.
7
Ligands of Adrenergic Receptors: A Structural Point of View.肾上腺素能受体配体:从结构角度看。
Biomolecules. 2021 Jun 24;11(7):936. doi: 10.3390/biom11070936.
8
Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening.基于结构和配体的虚拟筛选发现靶向 GLP-1R 额外螺旋结合位点的新型别构调节剂。
Biomolecules. 2021 Jun 23;11(7):929. doi: 10.3390/biom11070929.
9
Trends in application of advancing computational approaches in GPCR ligand discovery.推进计算方法在 GPCR 配体发现中的应用趋势。
Exp Biol Med (Maywood). 2021 May;246(9):1011-1024. doi: 10.1177/1535370221993422. Epub 2021 Feb 27.
10
Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation.统计分析分子动力学模拟:提供激动剂依赖性 GPCR 激活的 P 值。
Sci Rep. 2020 Nov 17;10(1):19942. doi: 10.1038/s41598-020-77072-4.
有用诱饵目录增强版(DUD-E):更好的配体和诱饵,用于更好的基准测试。
J Med Chem. 2012 Jul 26;55(14):6582-94. doi: 10.1021/jm300687e. Epub 2012 Jul 5.
4
ZINC: a free tool to discover chemistry for biology.ZINC:一款用于生物学的免费化学发现工具。
J Chem Inf Model. 2012 Jul 23;52(7):1757-68. doi: 10.1021/ci3001277. Epub 2012 Jun 15.
5
Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4.基于结构的配体发现用于趋化因子受体 CXCR4 的蛋白-蛋白界面。
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5517-22. doi: 10.1073/pnas.1120431109. Epub 2012 Mar 19.
6
In silico screening for agonists and blockers of the β(2) adrenergic receptor: implications of inactive and activated state structures.计算机筛选β(2)肾上腺素能受体激动剂和阻滞剂:无活性和激活状态结构的意义。
J Comput Chem. 2012 Feb 15;33(5):561-72. doi: 10.1002/jcc.22893. Epub 2011 Dec 14.
7
Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.根据激动剂结合的 A₂A 腺苷受体晶体结构评估激动剂结合的分子建模。
J Med Chem. 2012 Jan 12;55(1):538-52. doi: 10.1021/jm201461q. Epub 2011 Dec 12.
8
Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.发现β-arrestin 偏向性多巴胺 D2 配体,用于探测对抗精神病药物疗效至关重要的信号转导途径。
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18488-93. doi: 10.1073/pnas.1104807108. Epub 2011 Oct 24.
9
Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.基于晶体结构的人源组胺 H(1)受体配体的类片段虚拟筛选。
J Med Chem. 2011 Dec 8;54(23):8195-206. doi: 10.1021/jm2011589. Epub 2011 Nov 7.
10
ChEMBL: a large-scale bioactivity database for drug discovery.ChEMBL:用于药物发现的大型生物活性数据库。
Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7. doi: 10.1093/nar/gkr777. Epub 2011 Sep 23.